ATE198829T1 - Chelate von aromatischen vitaminen mit (pi)- bindung - Google Patents

Chelate von aromatischen vitaminen mit (pi)- bindung

Info

Publication number
ATE198829T1
ATE198829T1 AT93918460T AT93918460T ATE198829T1 AT E198829 T1 ATE198829 T1 AT E198829T1 AT 93918460 T AT93918460 T AT 93918460T AT 93918460 T AT93918460 T AT 93918460T AT E198829 T1 ATE198829 T1 AT E198829T1
Authority
AT
Austria
Prior art keywords
vitamin
chelates
ligands
mineral
bond
Prior art date
Application number
AT93918460T
Other languages
English (en)
Inventor
Harvey H Ashmead
Original Assignee
Albion Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albion Int filed Critical Albion Int
Application granted granted Critical
Publication of ATE198829T1 publication Critical patent/ATE198829T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08Copper compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/06Zinc compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93918460T 1992-08-14 1993-07-28 Chelate von aromatischen vitaminen mit (pi)- bindung ATE198829T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/930,747 US5292729A (en) 1992-08-14 1992-08-14 II-bond aromatic vitamin chelates
PCT/US1993/007098 WO1994004141A1 (en) 1992-08-14 1993-07-28 π-BOND AROMATIC VITAMIN CHELATES

Publications (1)

Publication Number Publication Date
ATE198829T1 true ATE198829T1 (de) 2001-02-15

Family

ID=25459704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918460T ATE198829T1 (de) 1992-08-14 1993-07-28 Chelate von aromatischen vitaminen mit (pi)- bindung

Country Status (10)

Country Link
US (1) US5292729A (de)
EP (1) EP0662830B1 (de)
JP (1) JPH08502729A (de)
AT (1) ATE198829T1 (de)
AU (1) AU676195B2 (de)
BR (1) BR9306902A (de)
CA (1) CA2142358C (de)
DE (1) DE69329896T2 (de)
NZ (1) NZ255144A (de)
WO (1) WO1994004141A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
DK81095A (da) * 1995-07-11 1997-01-12 Henrik S Thomsen Peroralt MR-kontraststof til lever og øvre tarmkanal
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US6703056B2 (en) 2000-09-29 2004-03-09 The Procter + Gamble Co. Beverage compositions comprising arabinogalactan and defined minerals
US6706295B2 (en) 2000-09-29 2004-03-16 The Procter & Gamble Co. Compositions comprising arabinogalactan and a defined protein component
US20020110632A1 (en) * 2000-09-29 2002-08-15 The Procter & Gamble Co. Beverage compositions comprising arabinogalactan and defined vitamins
WO2002030948A2 (en) * 2000-10-11 2002-04-18 Albion International, Inc. A composition and method for preparing amino acid chelates free of interfering ions
US6710079B1 (en) 2000-10-11 2004-03-23 Albion International, Inc. Composition and method for preparing amino acid chelates and complexes free of interfering complex ions
US6407138B1 (en) 2000-10-11 2002-06-18 Albion International, Inc. Composition and method for preparing electrically neutral amino acid chelates free of interfering ions
DE60228632D1 (de) 2001-03-12 2008-10-09 Tosoh Corp Katalysator auf Basis einer Übergangsmetallverbindung für die Olefinpolymerisation und Verwendung des Katalysators für die Olefinpolymerisation
US6632449B2 (en) 2001-11-20 2003-10-14 The Procter & Gamble Co. Compositions and kits comprising a defined boron compound and methods of their preparation
US20060013892A1 (en) * 2001-11-28 2006-01-19 Albion International Inc. Administration of amino acid chelates for reduction in alcohol dependency
US7910137B2 (en) * 2001-11-28 2011-03-22 Albion International, Inc. Metal carnitine chelates
US20030158171A1 (en) * 2001-11-28 2003-08-21 Albion International, Inc. Chelates and complexes for reduction in alcohol dependency
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
JP4569802B2 (ja) * 2003-07-23 2010-10-27 眞 八藤 ビタミンを主材とするイオン化ミネラル結合型サプリメントの製造方法
US20050239763A1 (en) * 2004-04-21 2005-10-27 Albion International, Inc. Non-GMO metal amino acid chelates and non-GMO metal amino acid chelate-containing compositions
US7838042B2 (en) * 2004-04-21 2010-11-23 Albion International, Inc. Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions
US20050235718A1 (en) * 2004-04-21 2005-10-27 Kevin Dickinson Organic amino acid chelates, methods for making such chelates, and methods for using such chelates
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
US20070270591A1 (en) * 2006-05-16 2007-11-22 Ashmead H Dewayne Iron (II) amino acid chelates with reducing agents attached thereto
US20080194679A1 (en) * 2007-02-14 2008-08-14 Ashmead H Dewayne Compositions and methods for increasing metabolic activity in animal tissue
US20080194407A1 (en) * 2007-02-14 2008-08-14 Ashmead H Dewayne High nitrogen containing chelate compositions suitable for plant delivery
US20090182044A1 (en) * 2008-01-11 2009-07-16 Ashmed H Dewayne Nitrate amino acid chelates
WO2015008825A1 (ja) * 2013-07-19 2015-01-22 株式会社三和化学研究所 口腔内崩壊錠
CN103739509B (zh) * 2014-01-09 2015-12-30 山东祥维斯生物科技股份有限公司 一种甘氨酸螯合锰的工业化生产制备工艺
US10258980B2 (en) * 2014-09-06 2019-04-16 C Lab Pharma International, S.A. Pure chelation process
PL3344063T3 (pl) * 2015-09-01 2023-03-06 Dupont Nutrition Biosciences Aps Sposoby zwiększenia wchłaniania witamin rozpuszczalnych w tłuszczach w paszy
CN112409202A (zh) * 2020-12-23 2021-02-26 河南九天生物科技有限公司 一种治疗和预防缺铁性贫血的氨基酸Fe(Ⅲ)螯合物及工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923855A (en) * 1983-07-08 1990-05-08 The William Seroy Group Synthetic GTF chromium material and process therefor
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
US5155224A (en) * 1988-09-27 1992-10-13 Salutar, Inc. Manganese (II) chelates
DE3937004A1 (de) * 1989-11-07 1991-05-08 Bayer Ag Metallkomplexverbindungen

Also Published As

Publication number Publication date
CA2142358A1 (en) 1994-03-03
DE69329896D1 (de) 2001-03-01
AU4790193A (en) 1994-03-15
JPH08502729A (ja) 1996-03-26
EP0662830A4 (en) 1995-08-16
BR9306902A (pt) 1998-12-08
CA2142358C (en) 2004-08-31
AU676195B2 (en) 1997-03-06
EP0662830B1 (de) 2001-01-24
EP0662830A1 (de) 1995-07-19
WO1994004141A1 (en) 1994-03-03
US5292729A (en) 1994-03-08
NZ255144A (en) 1997-02-24
DE69329896T2 (de) 2001-09-06

Similar Documents

Publication Publication Date Title
DE69329896D1 (de) CHELATE VON AROMATISCHEN VITAMINEN MIT (pi)-BINDUNG
MY107865A (en) Calcium and trace mineral supplements.
GB2367293A (en) Bioavailable chelates of creatine and essential metals
ZA867387B (en) Pharmaceutical and dietary composition
AR015074A1 (es) Producto nutricional liquido, composicion nutricionalmente completa y metodo para su preparacion
CA2129852A1 (en) Method of providing selenium in nutritional products
MY102424A (en) Wood preservatives
IE830130L (en) Feeding-stuffs for ruminants
MY103203A (en) Shrimp feed
GR3003272T3 (en) Nutritional supplement for treatment of uremia
CA2182987A1 (en) Novel phosphoric acid-amino acid complex salt and additive composition containing the salt and used in feed for ruminant mammals
MXPA02010643A (es) Un metodo de tratamiento de proteinas de soya y un producto de proteina de soya producido mediante este metodo.
AU553414B2 (en) Particulate amino acid zinc complex feed additive
DK469488D0 (da) Litiumholdigt ernaeringssupplement
MX9307737A (es) Optimizacion de utilizacion de proteina dietetica mediante administracion de quelatos de amino acido.
WO1984004243A3 (fr) Composition de mineraux injectables a usage veterinaire
Dierberg et al. Water chemistry of a Florida cypress dome.
Ely et al. Amino and urea nitrogen levels in lambs receiving different nitrogen sources and injections of lysine and methionine
EP0063328A3 (de) Sekretin enthaltende Zusammensetzungen und Verfahren zur Verhütung der Adsorption von Sekretin
Kruse-Jarres et al. Pathobiochemical Aspects to the Mechanism of Zinc Absorption
Hilsdorf Japan Leads in Developing Advanced Ceramics
JPS52108895A (en) Automatic separating apparatus for papers
Hubicki Purification of Zinc Salts From Cadmium (II), Lead (II), Copper (II), Nickel (II), Iron (III), Indium (III), and Gallium (III) on Chelating Ion Exchangers
FR2390110A1 (fr) Bloc alimentaire pour mammiferes ruminants et procede de preparation de celui-ci
GB1269898A (en) Amino acid derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties